Table 8 : Correlation of DNA-ploidy with occurrence of lymphnode-or bone metastases.


Authors Year Journal Number of
patients
Months of
follow-up
Significance p Flow/Image
cytometry
Lymph
nodes/Bone
Remarks

After RPE

Oxford level 2b

Ross et al., [170] 1994 Cancer 89 31.2 0.006 ICM   --
Ross et al., [229] 1993 Cancer 100 At primary
diagnosis
0.0001 ICM L & B 71 after
laparatomy
Winkler et al., [186] 1988 Mayo Clin Rep 91 90 <0.0001 FCM B D1

Oxford level 3b

Ross et al., [173] 1994 Mod Pathol 56 28.8 0.0026 ICM L. B --

Oxford level 4

Tucci et al., [57] 1994 Brazilian J Med
Biol Res
28 50 0.03 ICM B --

After hormonal therapy

Oxford level 3b

Tribukait [235] 1993 Eur Urol 309 176 <0.0001 FCM   --
Eskelinen et al., [227] 1991 Eur Urol 91 187 0.0601 FCM Ln --

Bold p-values refer to Cox multivariate regression analysis.

Böcking et al.Pathology Discovery  2014 2:7DOI : 10.7243/2052-7896-2-7